Fortis Healthcare

609.90
+6.80
(1.13%)
Market Cap
46,044.90 Cr
EPS
7.93
PE Ratio
57.78
Dividend Yield
0.17 %
52 Week High
744.50
52 Week low
375.05
PB Ratio
5.81
Debt to Equity
0.14
Sector
Hospitals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from13 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy92.31 %
92.31 %
Hold0.0 %
0.0 %
Sell7.69 %
7.69 %

Company News

View All News
Caret
positive
Fortis Healthcare Acquires Shrimann Superspecialty Hospital6 days ago
Fortis Healthcare has signed agreements to acquire the operations of Shrimann Superspecialty Hospital. The acquisition includes the hospital building and associated land parcels for a total consideration of 4.62 billion rupees.
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,031.85 1,00,309.45 93.41 5,584.10 18.77 1,058 -17.46 42.11
6,390.95 91,892.06 70.44 19,165.50 14.74 917 49.14 37.64
609.90 46,044.90 57.78 6,931.20 8.99 645 89.49 40.42
1,206.40 32,402.38 60.82 2,759.20 25.09 326 15.71 58.91
1,404.55 28,703.50 35.83 5,093.40 10.96 790 2.66 56.00
542.00 21,687.53 61.72 2,511.20 12.94 336 20.76 27.74
417.30 20,844.68 80.07 3,723.70 22.85 205 -69.22 30.11
6,150.00 15,982.15 32.44 599.90 11.69 58 8.85 58.63
1,299.55 13,197.15 54.81 1,334.00 10.76 218 10.06 32.06
1,489.85 9,768.35 50.32 1,095.50 21.32 177 20.14 38.20
Growth Rate
Revenue Growth
8.99 %
Net Income Growth
1.93 %
Cash Flow Change
33.79 %
ROE
-3.46 %
ROCE
14.14 %
EBITDA Margin (Avg.)
3.01 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
1,085
1,152
1,150
1,024
1,106
1,176
1,257
1,630
1,164
1,229
1,258
1,175
1,108
1,081
1,156
1,164
1,528
1,170
1,277
1,178
1,133
614
1,029
1,205
1,278
1,733
1,475
1,487
1,391
1,519
1,682
1,586
1,669
1,667
1,788
1,699
1,803
1,873
2,006
1,975
Expenses
1,022
986
1,087
1,066
1,091
1,059
1,097
1,023
1,045
1,071
1,138
1,069
1,907
1,034
1,172
1,193
1,069
996
1,028
1,012
987
709
875
987
1,055
1,135
1,178
1,180
1,157
1,237
1,304
1,283
1,372
1,386
1,440
1,396
1,405
1,516
1,613
1,553
EBITDA
62
166
62
-42
15
118
160
607
118
158
120
106
-799
47
-16
-29
459
174
250
166
146
-96
155
218
223
598
297
307
234
282
378
302
297
282
349
303
398
356
393
422
Operating Profit %
3 %
4 %
-2 %
-5 %
-2 %
6 %
8 %
10 %
7 %
7 %
5 %
5 %
-76 %
1 %
-3 %
-8 %
10 %
13 %
15 %
13 %
11 %
-17 %
12 %
16 %
16 %
20 %
19 %
20 %
16 %
17 %
19 %
18 %
16 %
16 %
19 %
17 %
21 %
18 %
19 %
19 %
Depreciation
61
53
0
0
72
48
52
60
63
59
61
59
60
57
56
60
60
71
71
70
80
72
74
73
72
73
75
76
77
74
77
83
82
79
84
87
92
91
95
97
Interest
37
34
30
32
38
42
46
75
67
64
66
63
64
76
85
111
65
51
49
48
57
41
42
42
41
38
40
38
30
31
33
33
32
32
32
33
35
35
36
45
Profit Before Tax
-22
88
44
-58
-96
28
62
472
-11
35
-7
-17
-924
-87
-157
-201
334
52
130
48
9
-208
38
103
110
486
182
193
126
176
268
186
183
171
233
183
271
230
261
279
Tax
-10
-9
-17
-29
-8
3
24
19
26
12
17
3
-9
-34
-15
-20
183
-26
6
118
50
-20
23
49
48
56
51
51
39
42
50
44
45
47
49
49
68
56
68
25
Net Profit
-12
97
61
-29
-88
25
38
453
-38
23
-24
-19
-914
-53
-142
-180
151
78
124
-69
-41
-188
16
54
62
431
131
142
87
134
218
142
138
124
184
134
203
174
193
254
EPS in ₹
-0.38
2.01
1.19
-0.65
-1.91
0.35
0.68
9.49
-0.79
0.10
-0.88
-0.71
-17.97
-1.36
-3.21
-3.06
1.80
0.90
1.47
-1.01
-0.59
-2.37
-0.05
0.40
0.57
3.49
1.42
1.55
0.90
1.62
2.71
1.72
1.76
1.48
2.30
1.78
2.37
2.20
2.34
3.28

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
Fixed Assets
4,218
3,776
5,419
4,992
8,477
8,802
8,799
9,416
9,426
9,874
Current Assets
1,636
1,434
1,775
1,282
1,667
941
1,037
1,133
1,406
1,421
Capital Work in Progress
228
201
268
226
450
204
165
194
228
542
Investments
616
1,449
1,878
1,732
270
175
186
104
210
230
Other Assets
2,554
1,807
2,152
1,672
2,755
2,167
2,005
2,172
2,569
2,643
Total Liabilities
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
Current Liabilities
1,602
1,476
1,927
2,134
3,591
2,579
1,233
1,269
1,426
3,170
Non Current Liabilities
1,813
1,616
1,480
1,171
1,248
1,563
3,204
3,607
2,907
1,563
Total Equity
4,201
4,140
6,311
5,317
7,113
7,206
6,718
7,008
8,100
8,556
Reserve & Surplus
3,585
3,534
4,626
3,543
5,846
5,906
5,365
5,423
6,487
6,908
Share Capital
463
463
518
519
755
755
755
755
755
755

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-66
-38
225
-513
799
-627
212
-153
-22
125
Investing Activities
213
122
-1,001
-333
-3,279
64
-131
-501
-373
-889
Operating Activities
24
195
967
493
-179
172
486
865
822
1,100
Financing Activities
-304
-354
259
-672
4,257
-862
-143
-517
-471
-87

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
26.32 %
0.00 %
23.24 %
23.31 %
25.26 %
26.77 %
DIIs
13.44 %
15.20 %
15.66 %
15.50 %
16.72 %
17.44 %
19.94 %
20.38 %
20.70 %
22.16 %
26.55 %
29.35 %
31.15 %
32.31 %
30.73 %
30.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.96 %
15.16 %
15.98 %
14.89 %
13.96 %
13.58 %
12.92 %
12.39 %
12.05 %
11.80 %
11.13 %
11.04 %
10.82 %
10.47 %
10.36 %
10.21 %
Others
41.43 %
38.47 %
37.20 %
38.44 %
38.15 %
37.82 %
35.98 %
36.06 %
36.08 %
34.86 %
4.83 %
28.44 %
3.63 %
2.75 %
2.48 %
1.81 %
No of Share Holders
0
1,09,889
1,44,634
1,66,743
1,54,572
1,56,881
1,60,762
1,58,455
1,37,894
1,35,047
1,31,516
1,35,664
1,57,165
1,54,260
2,04,184
2,21,750

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.17 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication
1 day ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
2 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
6 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
6 days ago
Acquisition Of Shrimann Superspecialty Hospital.
6 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release
6 days ago
Announcement under Regulation 30 (LODR)-Acquisition
6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
10 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 08, 2025, 12:30
Statement Of Deviation And Variation.
Feb 07, 2025, 19:09
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 07, 2025, 18:52
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 07, 2025, 18:48
Compliances-Reg. 54 - Asset Cover details
Feb 07, 2025, 18:43
Integrated Filing (Financial)
Feb 07, 2025, 18:38
Updated Policy Of Materiality Of Events
Feb 07, 2025, 18:07
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Feb 07, 2025, 18:03
Outcome Of The Board Meeting Under Regulation 30 And Regulation 51(2) And 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015
Feb 07, 2025, 18:00
Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And Regulation 51(2) And 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulat
Feb 07, 2025, 17:56
Reschedule Of Investor/Analysts Meet
Feb 07, 2025, 17:16
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 07, 2025, 17:09
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015.
Feb 06, 2025, 18:57
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 29, 2025, 12:43
Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jan 29, 2025, 11:55
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Jan 17, 2025, 17:29
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Jan 16, 2025, 22:18
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)
Jan 16, 2025, 22:12
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 15, 2025, 18:46
Announcement Under Regulation 30 Of SEBI (LODR) - Change In Designation
Dec 27, 2024, 11:44
Appointment Of Chairman.
Dec 27, 2024, 11:40
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dec 27, 2024, 11:38
Announcement under Regulation 30 (LODR)-Change in Directorate
Dec 27, 2024, 11:36
Board Meeting Outcome for Outcome Of The Board Meeting-December 27 2024
Dec 27, 2024, 11:34

Technical Indicators